Syndax Pharmaceuticals (SNDX) Amortizatization of Intangibles (2019 - 2026)

Syndax Pharmaceuticals' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $862000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 76.05% year-over-year to $862000.0; the TTM figure through Mar 2026 stood at $8.0 million (down 39.48% YoY), while the FY2025 annual figure was $10.8 million, down 20.16% from the prior year.
• Amortizatization of Intangibles was $862000.0 for Q1 2026 at Syndax Pharmaceuticals, down from $1.5 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.0 million in Q1 2023 to a low of $53000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $2.5 million across 5 years, with a median of $3.1 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 7384.91% in 2023, then slumped 76.05% in 2026.
• A 5-year view of Amortizatization of Intangibles shows it stood at $2.0 million in 2022, then surged by 70.81% to $3.5 million in 2023, then dropped by 15.0% to $2.9 million in 2024, then tumbled by 47.96% to $1.5 million in 2025, then sank by 43.66% to $862000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $862000.0 (Q1 2026), $1.5 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.